GlassScriptPhysician profile
William L Barry
NPI 1598752644
$5,696.51
in general payments reported to CMS, 2019-2025
24 companies · $709 in 2025
The $709 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $1,867 · 2021: $683 · 2022: $928 · 2023: $490 · 2024: $319 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,986.23 | 2019-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $1,477.88 | 2020-2023 | Inspiris Resilia Aortic Valve |
| E.R. Squibb & Sons, L.L.C. | $376.16 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $346.26 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $271.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $222.45 | 2019-2025 | |
| Medtronic, INC. | $195.05 | 2021-2023 | Onyx Frontier |
| Abbott Laboratories | $136.02 | 2019-2022 | |
| Chiesi USA, INC. | $84.59 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.42 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $70.42 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $66.57 | 2022-2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.02 | 2019-2022 | |
| Inspire Medical Systems, INC. | $54.28 | 2025 | Inspire |
| Bridgebio Pharma, INC. | $52.74 | 2025 | Attruby |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $42.88 | 2020 | |
| Janssen Pharmaceuticals, INC | $38.02 | 2019-2020 | |
| Asahi Intecc USA, INC. | $30.53 | 2019 | |
| Abiomed | $24.54 | 2024 | Impella |
| Heartflow, INC. | $17.86 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $17.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.22 | 2022 | |
| Cardinal Health 200 LLC | $14.54 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.